Kari Kustaa Alitalo (born 21 May 1952 in Kuopio) is a Finnish MD and a medical researcher. He is a foreign associated member of the National Academy of Sciences of the US.National Academy of Sciences Members and Foreign Associates Elected News, April 30th, 2013, National Academy of Sciences. Accessed June 3, 2013 He became famous for his discoveries of several receptor tyrosine kinases (RTKs) and the first growth factor capable of inducing lymphangiogenesis: vascular endothelial growth factor C (VEGF-C). In the years 1996–2007 he was Europe's second most cited author in the field of cell biology."Publication Analysis 1996-2007. Cell Biology." Lab Times. 2007. Number 5, pages 42-44 Alitalo is currently serving as an Academy Professor for the Academy of Finland.
Alitalo received the Leopold Griffuel Prize in 2002Leopold Griffuel Prize. Wikipedia. Accessed June 3rd, 2013 and the 2006 Louis-Jeantet Prize for Medicine. He also received the 2005 Eric Fernström Foundation's Nordic PrizeKari Alitalo received recognition for his work, University of Helsinki 2005 annual report. Accessed August 21, 2011 and the 2009 In-Bev Baillet Latour Health Prize.FINISH PROFESSORS KARI ALITALO AND SEPPO YLÄ-HERTTUALA ARE RECIPIENTS OF THE INBEV-BAILLET LATOUR HEALTH PRIZE 2009 FOR THEIR PIONEERING RESEARCH ON CARDIOVASCULAR DISORDERS. Press-release, April 2009, In-Bev Baillet Latour Foundation. Accessed August 21, 2011 In 2014, he received the Dr. A.H.Heineken Prize for Medicine.
References
External links Personal webpage, University of Helsinki